Chemotherapy versus palliative care in non-small cell lung cancer

Anti-Cancer Drugs

Volumn 11, Issue 8, 2000, Pages 603-607

  Nicum, S ^a   Cullen, M H ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Non small cell lung cancer; Palliative care

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; IFOSFAMIDE; MITOMYCIN;

CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; HUMAN; LUNG NEOPLASMS; META-ANALYSIS; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 0033787867     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200009000-00001     Document Type: Review

References (31)

1. Lung cancer: Worldwide variation in occurrence and proportion attributable to tobacco use
2. Cancer statistics 1997
3. NSCLC
4. Cancer statistics
5. Palliative chemotherapy: No longer a contradiction in terms
6. The use of nitrogen mustards in the palliative treatment of carcinoma (with particular reference to bronchogenic carcinoma)
7. Preferences for chemotherapy in patients with advanced NSCLC: Descriptive study based on scripted interviews
8. Polychemotherapy in advanced NSCLC: A meta-analysis
9. Chemotherapy in NSCLC: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
10. Cancer of the lung
11. Chemotherapy of NSCLC according to disease extent: A meta-analysis of the literature
12. Mitomycin, ifosfamide and cisplatin in NSCLC: Treatment good enough to compare
13. A randomized trial comparing pre-operative chemotherapy plus surgery with surgery lone in patients with NSCLC
14. Chemotherapy of advanced NSCLC - A comparison of 3 active regimens - A randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
15. MIC in unresectable NSCLC: Effects on survival and quality of life
16. Phase III trial of neo-adjuvant chemotherapy in resectable stage 1 (except T1N0), II, IIIa NSCLC: The French experience
17. Pacitaxel plus carboplatin in advanced NSCLC: A phase III trial
18. Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced NSCLC
19. Randomised study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced NSCLC: Results of a European multicentre trial including 612 patients
20. Chemotherapy can prolong survival in patients with advanced NSCLC: Report of a Canadian multicentre randomised trial
21. Cisplatin, cyclophosphamide, mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic NSCLC
22. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced NSCLC
23. Efficacy and safety profile of gemcitabine in NSCLC: A phase II study
24. Single agent activity of weekly gemcitabine in advanced NSCLC: A phase II study
25. Maximum tolerated dose defined for single agent gemcitabine: A phase I dose escalation study in chemotherapy naive patients with advanced NSCLC
26. Activity of gemcitabine in patients with NSCLC: A multicentre extended phase II study
27. Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced NSCLC
28. Randomised study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced NSCLC: Results of a European multicentre trial including 612 patients
29. Effects of vinorelbine on quality of life and survival of elderly patients with advanced NSCLC
30. Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced NSCLC
31. Prospective randomized trail of docetaxel versus best supportive care in patients with NSCLC previously treated with platinum based chemotherapy